Your SlideShare is downloading. ×
0
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Management of hypertension in elderly person.
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Management of hypertension in elderly person.

870

Published on

HYPERTENSION IN OCTAGENERIAN AND BEYOND.

HYPERTENSION IN OCTAGENERIAN AND BEYOND.

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
870
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
41
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Elderly > 65 yrs
  • Transcript

    • 1. PRESENTATION 81-YEAR-OLD FEMALE NON-SMOKER-DIAGNOSED WITH STAGE 2 HYPERTENSION, BY ANOTHER PRACTIONER 1 MONTH AGO AND ABPM DONE HER CLINIC BLOOD PRESSURE WAS 174/102 mmHG AND HER ABPM AVERAGE WAS 170/100 mmHG CUT OFF FOR ABPM?MEDICAL HISTORY NO SIGNIFICANT MEDICAL HISTORY. NON-DIABETIC
    • 2. POINTS TO PONDER OVER… WHAT TESTS TO ORDER NOW? WHAT IS INITIAL TREATMENT? WHAT IS THE CV RISK? WHAT IS THE DIFFERENCE IN YOUNG AND ELDERLY IN HTN TREATMENT?
    • 3. QUESTIONWHAT TESTS YOU ORDER NOW? WHAT IS INITIALTREATMENT? APPROPRIATE TESTS FOR TARGET ORGAN DAMAGE AND CARDIOVASCULAR RISK ASSESSMENT GIVEN HER AGE, SHE WILL SCORE VERY HIGHLY IN ALL CARDIOVASCULAR RISK ASSESSMENTS INITIAL APPROPRIATE TREATMENT IS WITH A CALCIUM-CHANNEL BLOCKER
    • 4. • Offer people aged 80 years and over the same antihypertensive drug treatment as people aged 55—80 years, taking into account any comorbidities. [New 2011]
    • 5. RECOMMENDATIONS1. OFFER ANTIHYPERTENSIVE DRUG TREATMENT TO PEOPLE AGED UNDER 80 YEARS WITH STAGE 1 HYPERTENSION WHO HAVE ONE OR MORE OF THE FOLLOWING: TARGET ORGAN DAMAGE ESTABLISHED CARDIOVASCULAR DISEASE RENAL DISEASE DIABETES A 10-YEAR CARDIOVASCULAR RISK EQUIVALENT TO 20% OR GREATER. [NEW 2011]2.OFFER ANTIHYPERTENSIVE DRUG TREATMENT TO PEOPLE OF ANY AGE WITH STAGE 2 HYPERTENSION. [NEW 2011]
    • 6. RECOMMENDATIONS Use clinic blood pressure measurements to monitor the response to antihypertensive treatment with lifestyle modifications or drugs. [New 2011]
    • 7. WHAT DRUG/S IF HEART FAILURE + If a CCB is not suitable, for example because of oedema or intolerance, or if there is evidence of heart failure or a high risk of heart failure, offer a thiazide-like diuretic. [New 2011]
    • 8.  If diuretic treatment is to be initiated or changed, offer a thiazide-like diuretic, such as chlortalidone (12.5—25.0 mg once daily) or indapamide (1.5 mg modified-release or 2.5 mg once daily) in preference to a conventional thiazide diuretic such as bendroflumethiazide or hydrochlorothiazide. [New 2011]
    • 9.  ONE MONTH LATER Patient’s total cholesterol is 148 mg/dland her HDL is 50 mg/dl.Glucose is normal. There is no left ventricular hypertrophy or atrial fibrillation on ECG. Her 10-year cardiovascular risk is 27%.(Using QRISK2) You measure her clinic blood pressure and it is 165/100 mmhg. What would you do next?
    • 10.  BLOOD PRESSURE IS NOT CONTROLLED. CHECK ADHERENCE WITH STEP 1 TREATMENT. IDENTIFY IF YOU CAN HELP ENHANCE ADHERENCE - MODIFY DOSING REGIMEN, - PROVIDE A RECORD FOR HER TO MONITOR HER MEDICINE TAKING).
    • 11.  Aim for a target clinic blood pressure below 150/90 mmhg in people aged 80 years and over, with treated hypertension. [New 2011]
    • 12.  IF BLOOD PRESSURE IS NOT CONTROLLED BY STEP 1 TREATMENT, OFFER STEP 2 TREATMENT WITH A CCB IN COMBINATION WITH EITHER AN ACE INHIBITOR OR AN ARB. [NEW 2011]
    • 13.  SHE RETURNS TO THE CLINIC AFTER A MONTH. HER CLINIC BLOOD PRESSURE IS 154/90 mmHG. WHAT NEXT?
    • 14.  Review her antihypertensive medications and ensure optimal or best tolerated dose. Ensure adherence to the drug regimen and review any factors that may reduce her compliance A blood test to check her electrolytes around 2 weeks after starting the ace inhibitor and to return to the clinician after 1 month Follow the results of the electrolyte test and a further review of her blood pressure.
    • 15. USEFUL INTERVENTIONS RECORDING THE MEDICINE-TAKING BY PATIENT ENCOURAGING PATIENTS TO MONITOR THEIR CONDITION SIMPLIFYING THE DOSING REGIMEN USING ALTERNATIVE PACKAGING USING A MULTI-COMPARTMENT MEDICINES SYSTEM.
    • 16. 3 MONTHS LATER CLINIC APPOINTMENT BLOOD PRESSURE IS 145/85 MMHG. AN ACCEPTABLE BLOOD PRESSURE FOR A PERSON OVER 80. SHE CAN STAY ON CURRENT TREATMENT.
    • 17. RECOMMENDATIONS AIM FOR A TARGET CLINIC BLOOD PRESSURE BELOW 150/90 MMHG IN PEOPLE AGED 80 YEARS AND OVER, WITH TREATED HYPERTENSION. [NEW 2011] BEFORE CONSIDERING STEP 3 TREATMENT, REVIEW MEDICATION TO ENSURE STEP 2 TREATMENT IS AT OPTIMAL OR BEST TOLERATED DOSES. [NEW 2011] USE INTERVENTIONS TO OVERCOME PRACTICAL PROBLEMS ASSOCIATED WITH NON-ADHERENCE IF A SPECIFIC NEED IS IDENTIFIED.
    • 18. < 79 yrs, achieved SBP values <140 mm Hg are appropriate goals>80 yrs, 140 to 145 mm Hg, if tolerated, can be acceptable.SBP <130 and DBP <65 mm Hg should be avoidedLow-dose thiazides, CAs, and RAAS blockers are preferred,.

    ×